Northern Trust’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Sell |
98,548
-231,476
| -70% | -$336K | ﹤0.01% | 4030 |
|
|
2025
Q1 | $455K | Buy |
330,024
+7,928
| +2% | +$10.9K | ﹤0.01% | 3610 |
|
|
2024
Q4 | $979K | Sell |
322,096
-2,180
| -0.7% | -$6.63K | ﹤0.01% | 3403 |
|
|
2024
Q3 | $1.61M | Buy |
324,276
+226,764
| +233% | +$1.13M | ﹤0.01% | 3125 |
|
|
2024
Q2 | $570K | Buy |
97,512
+20,552
| +27% | +$120K | ﹤0.01% | 3460 |
|
|
2024
Q1 | $611K | Buy |
76,960
+5,349
| +7% | +$42.5K | ﹤0.01% | 3494 |
|
|
2023
Q4 | $417K | Sell |
71,611
-365
| -0.5% | -$2.13K | ﹤0.01% | 3604 |
|
|
2023
Q3 | $184K | Buy |
71,976
+56,921
| +378% | +$146K | ﹤0.01% | 3844 |
|
|
2023
Q2 | $37.6K | Buy |
15,055
+905
| +6% | +$2.26K | ﹤0.01% | 4283 |
|
|
2023
Q1 | $29.7K | Buy |
14,150
+2,905
| +26% | +$6.1K | ﹤0.01% | 4375 |
|
|
2022
Q4 | $17.4K | Buy |
+11,245
| New | +$17.4K | ﹤0.01% | 4514 |
|